Taysha Gene Therapies annual debt-to-equity ratio
2021
2022
2023
2024
2025
Taysha Gene Therapies Debt-to-Equity Ratio Growth & History (TSHA)
Taysha Gene Therapies's debt-to-equity ratio was 0.28 for fiscal 2025.
View full Taysha Gene Therapies company overviewTaysha Gene Therapies annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.28 | −0.60 | −68.03% |
| 2024 | 2024-12-31 | 0.89 | 0.06 | +7.60% |
| 2023 | 2023-12-31 | 0.83 | −63.52 | −98.72% |
| 2022 | 2022-12-31 | 64.34 | 63.95 | +16401.07% |
| 2021 | 2021-12-31 | 0.39 | — | — |
Taysha Gene Therapies quarterly debt-to-equity ratio
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.15 | −0.09 | −39.05% |
| Q1 2026 | 2026-03-31 | 0.32 | −0.80 | −71.10% |
| Q4 2025 | 2025-12-31 | 0.28 | −0.60 | −68.03% |
| Q3 2025 | 2025-09-30 | 0.32 | −0.39 | −55.55% |
| Q2 2025 | 2025-06-30 | 0.24 | −0.30 | −55.13% |
| Q1 2025 | 2025-03-31 | 1.12 | −0.02 | −1.81% |
| Q4 2024 | 2024-12-31 | 0.89 | 0.06 | +7.60% |
| Q3 2024 | 2024-09-30 | 0.71 | — | — |
| Q2 2024 | 2024-06-30 | 0.54 | — | — |
| Q1 2024 | 2024-03-31 | 1.14 | — | — |
| Q4 2023 | 2023-12-31 | 0.83 | −63.52 | −98.72% |
| Q4 2022 | 2022-12-31 | 64.34 | 63.95 | +16401.07% |
| Q3 2022 | 2022-09-30 | 3.53 | 3.33 | +1681.53% |
| Q2 2022 | 2022-06-30 | 1.16 | — | — |
| Q1 2022 | 2022-03-31 | 0.74 | — | — |
| Q4 2021 | 2021-12-31 | 0.39 | — | — |
| Q3 2021 | 2021-09-30 | 0.20 | — | — |
Taysha Gene Therapies debt-to-equity ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Taysha Gene Therapies's debt-to-equity ratio decreased from 0.39 to 0.28, a change of −0.11. The latest reported quarter, Q2 2026, shows 0.15.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Taysha Gene Therapies source filings ↗